Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 6/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | ABAT | P80404 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 2/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | RGS12 | O14924 | 1/20 | 0.40 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.40 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL11674225 | 0.98 | EGFR (0.48) | EGFRTYRABATENPP2LCK | |
| Hydrochloric Acid SCHEMBL3562527 | 0.98 | EGFR (0.48) | EGFRTYRABATENPP2LCK | |
| SCHEMBL1044776 | 0.81 | RECQL (0.58) | EGFRTYRLCKHTR2CALDH1A1 | |
| SCHEMBL633312 | 0.80 | TYR (0.65) | TYRABATMAPTTDP1HTT | |
| SCHEMBL30255614 | 0.80 | TYR (0.65) | TYRABATMAPTTDP1HTT | |
| Bromide SCHEMBL10939970 | 0.79 | RECQL (0.56) | EGFRTYRLCKHTR2CALDH1A1 | |
| SCHEMBL50932 | 0.79 | MAPT (0.58) | EGFRTYRLCKALDH1A1MAPT | |
| SCHEMBL10012940 | 0.79 | TYR (0.64) | EGFRTYRLCKALDH1A1TP53 | |
| SCHEMBL31244463 | 0.79 | MAPT (0.58) | EGFRTYRLCKALDH1A1MAPT | |
| SCHEMBL22499985 | 0.78 | BACE1 (0.52) | ABATENPP2ALDH1A1MAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220112156-A1 | ADAMANTANECARBOXYLIC ACID BENZYL AMIDE DERIVATIVE COMPOUND AND SKIN WHITENING COMPOSITION COMPRISING SAME | AMOREPACIFIC CORPORATION (KR) | 2022-04-14 | — | — | US | claimed |
| CN-113286779-A | Adamantane carboxylic acid benzylamide derivative compound and skin whitening composition containing same | 株式会社爱茉莉太平洋 | 2021-08-20 | — | — | CN | claimed |
| WO-2020141927-A1 | ADAMANTANECARBOXYLIC ACID BENZYL AMIDE DERIVATIVE COMPOUND AND SKIN WHITENING COMPOSITION COMPRISING SAME | ㈜아모레퍼시픽 | 2020-07-09 | — | — | WO | claimed |
| EP-0641311-A1 | NOVEL DIHYDROXYBENZYLAMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | Aventis Pharma S.A. (FR) | 1995-03-08 | — | — | EP | claimed |
| WO-1993023364-A1 | NOVEL DIHYDROXYBENZYLAMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1993-11-25 | — | — | WO | claimed |
| US-12017974-B2 | Adamantanecarboxylic acid benzyl amide derivative compound and skin whitening composition comprising same | AMOREPACIFIC CORPORATION (KR) | 2024-06-25 | — | — | US | disclosed |
| US-20240068988-A1 | SYSTEMS AND METHODS FOR RAPID PATHOGEN DETECTION | MARSHALL DARRELL D (US) | 2024-02-29 | — | — | US | disclosed |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | VANDERBILT UNIVERSITY | 2023-11-16 | — | — | US | disclosed |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | VANDERBILT UNIVERSITY | 2023-11-09 | — | — | US | disclosed |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | MTI BIOTECH, INC. | 2023-10-19 | — | — | US | disclosed |
| US-11696903-B2 | Compounds and methods for scavenging dicarbonyl electrophiles | VANDERBILT UNIVERSITY (US) | 2023-07-11 | — | — | US | disclosed |
| US-20230181494-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDEHYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), NASH, ALD OR CONDITIONS RELATED TO THE LIVER | MTI BIOTECH, INC. | 2023-06-15 | — | — | US | disclosed |
| US-4387154-A | SPACED MICROVESSELS HAVING A SURFACE OPENING FILLED WITH PHOTOSENSITI MATERIAL; ANTIHALATION AGENTS; SUPPRESSION OF IMAGE SPREADING; X-RAY COLOR; BLACK AND WHITE FILMS | EASTMAN KODAK COMPANY (US) | 1983-06-07 | — | — | US | disclosed |
| US-4375507-A | Imaging with nonplanar support multicolor filter elements | EASTMAN KODAK COMPANY (US) | 1983-03-01 | — | — | US | disclosed |
| US-4367279-A | Silver halide complexing agents of sulfones, nitriles, and onium salts | EASTMAN KODAK COMPANY (US) | 1983-01-04 | — | — | US | disclosed |
| US-4362806-A | PHOTOGRAPHY, SILVER HALIDE EMULSIONS | EASTMAN KODAK COMPANY (US) | 1982-12-07 | — | — | US | disclosed |
| US-4228230-A | Ultrasonic imaging of internally fogged silver halide elements | EASTMAN KODAK COMPANY (US) | 1980-10-14 | — | — | US | disclosed |
| EP-0013652-A2 | Ultrasonographic process | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1980-07-23 | — | — | EP | disclosed |
| US-4139379-A | Photographic elements containing ballasted electron-accepting nucleophilic displacement compounds | EASTMAN KODAK COMPANY (US) | 1979-02-13 | — | — | US | disclosed |
| US-4065435-A | OXIDATION-REDUCTION PROPERTIES, ACRYLIC | FUJI PHOTO FILM CO., LTD. (JA) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12017974-B2 | Adamantanecarboxylic acid benzyl amide derivative compound and skin whitening composition comprising same | TYR, DDC, AANAT | EGFR 2449/4885TYR 1/4885ABAT 495/4885 |
| US-20230181494-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDEHYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), NASH, ALD OR CONDITIONS RELATED TO THE LIVER | CPT1A, AKR7A2, FABP1 | EGFR 4791/4885TYR 2039/4885ABAT 69/4885 |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | HACL2, APOB, OAT | EGFR 3309/4885TYR 1786/4885ABAT 572/4885 |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | FABP2, SI, MLN | EGFR 2948/4885TYR 2399/4885ABAT 1684/4885 |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | GGT1, GGH, AKR7A2 | EGFR 4789/4885TYR 2388/4885ABAT 330/4885 |
| US-20220112156-A1 | ADAMANTANECARBOXYLIC ACID BENZYL AMIDE DERIVATIVE COMPOUND AND SKIN WHITENING COMPOSITION COMPRISING SAME | TYR, DDC, AANAT | EGFR 2449/4885TYR 1/4885ABAT 495/4885 |
| US-11696903-B2 | Compounds and methods for scavenging dicarbonyl electrophiles | OGG1, LGMN, GLO1 | EGFR 4853/4885TYR 1161/4885ABAT 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.